Cardiac ischaemia: Possibilities for future drug therapy

European Journal of Medicinal Chemistry

Volumn 32, Issue 9, 1997, Pages 687-707

  Chatelain, P ^a   Massingham, R ^a  

^a UCB PHARMA   (Belgium)

Author keywords

Cardiac ischaemia; Future drugs; Remodelling; Vascular endothelium

Indexed keywords

ADENOSINE DERIVATIVE; ADENOSINE RECEPTOR; ANTITHROMBOCYTIC AGENT; BAMIFYLLINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIMAKALIM; BRIMONIDINE; CALCIUM ANTAGONIST; CARDIOVASCULAR AGENT; CORONARY VASODILATING AGENT; CROMAKALIM; DILAZEP; DILTIAZEM; DIPYRIDAMOLE; ENDOTHELIN; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; EPROSARTAN; ESMOLOL; GLIBENCLAMIDE; LIPOXYGENASE INHIBITOR; LOSARTAN; N HYDROXY N METHYL 3 [2 (METHYLTHIO)PHENYL]PROPENAMIDE; NIFEDIPINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; POTASSIUM CHANNEL AFFECTING AGENT; UNINDEXED DRUG; VASODILATOR AGENT; VERAPAMIL; ZATEBRADINE;

ANGINA PECTORIS; CARDIOVASCULAR SYSTEM; DRUG RESEARCH; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

EID: 0030847777     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(97)88912-X     Document Type: Review

References (182)

1. Kübler W, Haass M (1996) Heart 75, 330-333
2. Scandinavian Simvastatin Survival Study Group (1994) Lancet 344, 1383-1389
3. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillip JH, Packard CJ (1995) New Engl J Med 333, 1301-1307
4. Sacks FM, Pfeffer MA, Moye LA, et al (1996) N Eng J Med 335, 1001-1009
5. Ware JA, Simons M (1997) Nature Medicine 3, 158-164
6. Maseri A, (1990) Circulation 82, 2258-2262
7. Cohn PF (1992) Am J Cardiol 70, 14G-18G
8. Ambrose JA, Tannenbaum MA, Aleopoulos D, et al (1988) J Am Coll Cardiol 12, 56-62
9. Hackett D, Davies, G Maseri (1988) Eur Heart J 9, 1317-1323
10. Little WC, Constantinescu M, Applegate RJ, et al (1988) Circulation 78, 11576-1166
11. Giroud D, Li JM, Urban P, Meier B, Rutishauer W (1992) Am J Cardiol 69, 729-732
12. Ganz P, Creager MA, Fang JC, McConnel MV, Lee RT, Libby P, Selwyn AP (1996) Am J Med 101 (suppl 4A), 10S-16S
13. Vanhoutte PM (1987) Am J Cardiol 59, 3A-8A
14. The Danish Study Group on Verapamil in MI (1990) Am J Cardiol 66, 779-785
15. The Multicentre Diltiazem Postinfarction Trial Research Group (1988) New Eng J Med 319, 385-392
16. Hinstridge V, Speight TM (1991) Drugs 42 (Suppl 2), 8-20
17. Rauch B, Kübler W (1991) Cur Op Cardiol 6, 511-523
18. Friedman GD, Klatsky AL, Siegelaub AB (1975) Circulation 52 (Suppl III), III 164-III 169
19. Schroll M, Hagerup LM (1977) Danish Med Bull 24, 252-255
20. Dyer AR, Persky V, Stamler J, Paul O, Shekelle RB, Berkson DM, Lepper M, Schoenberger JA, Lindberg HA (1980) Am J Epidemiol 112, 736-749
21. Hjalmarson A, Gilpin EA, Kjekshus J, Schieman G, Nicod P, Henning H, Ross J Jr (1990) Am J Cardiol 65, 547-553
22. Frishman WH, Gabor R, Pepine C, Cavusoglu E (1996) Am Heart J 131, 204-210
23. Riley D, Gross G, Kampine J, Warltier D (1987) Anaesthesiology 67, 707-716
24. Van Bogaert PP, Goethals M (1992) Eur J Physiol 421, 55-61
25. Goethals M, Raes A, Bogaert PP (1993) Circulation 88, 2389-2401
26. Breall JA, Watanabe J, Grossman W (1993) J Am Coll Cardiol 21, 471-477
27. Indolfi C, Guth BD, Miura T, Miyazaki S, Schulz R, Ross J Jr (1991) Circulation 86, 983-993
28. Canty JM, Giglia J, Kandath D (1990) Circulation 82, 1815-1825
29. Frishman WH, Pepine CJ, Weiss R, Baiker WM (1995) J Am Coll Cardiol 26, 305-312
30. Findlay IN, MacLeod, Ford M, Gillen G, Elliott AT, Dargie HJ (1986) Br Heart J 55, 240-245
31. Gross GJ, Auchampach JA, (1992) Circ Res 70, 223-233
32. Mizumura T, Auchampach JA, Linden J, Bruns RF, Gross GJ (1996) Circ Res 79, 415-423
33. Gho BCG, Schoemaker RG, van den Doel MA, Duncker DJ, Verdouw PD (1996) Circulation 94, 2193-2200
34. Parratt JR (1994) Trends Pharmacol Sci 15, 19-25
35. Parratt JR, Szekeres L (1995) Trends Pharmacol Sci 16, 351-355
36. Brooks G, Hearse DJ (1996) Circ Res 79, 627-630
37. Lawson CS, Downey JM (1993) Cardiovasc Res 27, 542-550
38. Downey JM, Cohen MV (1996) In: Ischaemia: preconditioning and adaptation (Marber MM, Yellon DM, eds) BIOS Scientific Publishers Ltd, Oxford, 21-34
39. Bouchard JF, Lamontagne D (1996) Am J Physiol 40, H1801-H1806
40. Laurent S, Vanhoutte P, Cavero I, Chabrier PE, Dupuis B, Elghozi JL, Hamon G, Janiak P, Kher A, Koen R, Madonna O, Maffrand JP, Pruneau D, Thuillez C (1996) Fundamen Clin Pharmac 10, 243-257
41. Yeung AC, Raby KE, Gane P and Selwyn AP (1992) Am J Cardiol 70, 8G-13G
42. Shimokawa H, Vanhoutte PM (1989) Circ Res 64, 900-914
43. Furchgott RF, Zawadski JV (1980) Nature 288, 373-376
44. Palmer RMJ, Ferrige AG, Moncada S (1988) Nature 327, 524-526
45. Furlong B, Henderson AM, Lewis MJ, Smith JA (1987) Br J Pharmacol 90, 687-692
46. McCall T, Whittle BJR, Broughton-Smith NK (1988) Br J Pharmacol 95, 517P
47. Kubes P, Suzuki M, Grager GN (1991) Proc Natl Acad Sci USA 88, 4651-4655
48. Lefer DJ, Nakanishi K, Vinten-Johansen J (1993) J Cardiovasc Pharmac 22 (Suppl 7), S34-S43
49. Verbeuren TJ, Jordaens FH, Zonnekeyn LL, Van Hove CE, Coene MC, Herman AG (1986) Circ Res 58, 552-564
50. Yanagisawa M, Kurihara H, Kmura S, et al (1988) Nature 332, 411-415
51. Lüscher TF (1992) Br J Clin Pharmac 34, 29S-35S
52. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T (1990) Nature 348, 732-735
53. Miller RC, Pelton JT, Huggins JP (1993) Trends Pharmacol Sci 14, 54-60
54. Bogaert MG (1996) Drugs 52 (Suppl 4), 3-8
55. Ross R (1993) Nature 362, 801-808
56. Haylor J, Singh I, EL Nahas AM (1991) Kidney Int 39, 333-335
57. Buerke M, Murohara T, Skurk C, Nuss C, Tomaselli K, Lefer AM (1995) Proc Natl Acad Sci USA 92, 8031-8035
58. Malliani A, Schwartz PJ, Zanchetti A (1969) Am J Physiol 217, 703-709
59. Minisi AJ, Thames MD (1991) Circulation 84, 357-367
60. Kübler W, Strasser RH (1994) Eur Heart J 15, 437-445
61. Münch G, Kurz T, Urlbauer T, Seyfarth M, Richardt G (1996) Br J Pharmacol 118, 1855-1861
62. Schömig A, Fischer S, Kurz T, Richardt G, Schömig E (1987) Circ Res 60, 194-205
63. Schömig A (1990) Circulation 82(SupplII), II-13-II-22
64. Imamura M, Seyedi N, Lander H M, Levi R (1995) Circ Res 77, 206-210
65. Imamura M, Poli E, Omoniyi A T, Levi R (1994) J Pharmacol Exp Ther 271, 1259-1266
66. Imamura M, Lander H M, Levi R (1996) Circ Res 78, 475-481
67. Reitsma JB, Mosterd A, Koster RW, van Capelle FJL, Grobbee DE, et al (1994) Ned Tijdschr Geneesk 138, 866-871
68. Kannel WB (1989) Epidemiological aspects of heart failure. In: Congestive heart failure (Weber KT ed) WB Saunders Co, Philadelphia, 1-9
69. Weber KT, Brilla CG (1991) Circulation 83, 1849-1865
70. Cleutjens JPM (1996) Cardiovasc Res 32, 816-821
71. Struijker-Boudier HAJ, Smits JFM, De Mey JGR (1995) Ann Rev Pharmacol Toxicol 35, 509-539
72. Borg TK, Rubin K, Carver W, Samarel A, Terracio L (1996) Trends Cardiovasc Med 6, 65-70
73. Van Belle H (1993), Cardiovasc Res 27, 68-76
74. Griffiths M, Beaumont N, Yao SYM, Sundaram M, Boumah CE, Davies A, Kwong FYP, Coe I, Cass CE, Young JD, Baldwin SA (1997) Nature Medicine 3, 89-93
75. Przyklenk K, Zhao L, Kloner RA, Elliott GT (1996) Am J Physiol 271, H1004-H1014
76. Koichi N, Masafumi K, Tetsuo M, Michihiko T, Michitoshi I, Masatsugu H, Takenobu K (1997) Br J Pharmacol 120, 273-281
77. Bruns RF, Fergus JH, Coughenour LL, Courtland GG, Pugsley TA, Dodd JH, Tinney FJ (1990) Mol Pharmacol 38, 950-958
78. Bhattacharya S, Linden J (1995) Biochim Biophys Acta 1265, 15-21
79. Martin BJ, McClanahan TB, Hamilton HW, Gallagher KP (1993) Circulation 88 (Suppl I), I-430, Abst 2311
80. Mangano DT (1997) JAMA 277, 325-332
81. Magill M, Zhang C, Metzner K, Kopcho J, Mullane K, Bullough D (1993) Pharmacologist 35, 181 Abstract 280
82. Neely CF, Keith (1995) Am J Physiol 268, L1036-L1046
83. Neely CF, DiPierro FV, Kong M, Greelish JP, Gardner TJ (1996) Circulation 94, I1376
84. Zhao ZQ, Nakanishi K, McGee DS, Tan P, Vinten-Johansen JA (1994) Cardiovasc Res 28, 270-279
85. Nielsen-Kudsk JE, Boesgaard S, Aldershvile J (1996) Heart 76, 109-116
86. Escande D, Cavero I (1993) Potassium channel openers in the heart. In: K+ Channels in Cardiovasular Medicine (Escande D, Standen N, eds) Springer Verlag, Paris, 225-244
87. Mullane K (1993) Cardiovasc Res 27, 43-47
88. Lawson K (1996) Pharmacol Ther 70, 39-63
89. Atwal KS (1996) Current Med Chem 3, 227-238
90. Atwal KS, Grover GJ, Ahmed SZ, Ferrara FN, Harper TW, Kim KS, Sleph PG, Dzwonczyk S, Russell AD, Moreland S, McCullough JR, Normandin DE (1993) J Med Chem 36, 3971-3974
91. Grover GJ, McCullough JR, D'Alonzo AJ, Sargent CS, Atwal KS (1994) J Cardiovasc Pharmacol 25, 40-50
92. Yao Z, Gross GJ (1994) Circulation 89, 1769-1775
93. Paucek P, Mironova G, Mahdi F, Beavis AD, Woldegiorgis G, Garlid KD (1992) J Biol Chem 36, 29062-29069
94. Ohnmacht CJ, Russell K, Empfield JR, Frank CA, Gibson KH, Mayhugh DR, McLaren FM, Shapiro HS, Brown FJ, Trainor DA, et al (1996) J Med Chem 39, 4592-4601
95. Izhar U, Schwalb H, Borman JB, Merin G (1996) Isr J Med Sci 32 (Suppl) S38
96. Johnson III G, Tsao PS, Lefer AM (1991) Critical Care Medicine 19, 244-252
97. Boeger RH, Bode Boeger SM, Phivthong Ngam L, Boehme M, Brandes RP, Muegge A, Froelich JC (1996) Circulation 94, No 8 Suppl, I522
98. Parker JO, Reichek N, Julian DG (1989) Eur Heart J 10 (Suppl A), 1-55
99. Flaherty JT (1989) Drugs 37, 523-550
100. Anderson TJ, Meredith IT, Gane P, Selwyn PA, Yeung AC (1994) J Am Coll Cardiol 24, 555-566
101. Lefer AM, Lefer DJ (1994) Drug 19, 665-672
102. Kita Y, Ohkubo K, Hirasawa Y, Katayama Y, Ohno M, Nishino S, Kato M, Yoshida K (1995) Eur J Pharmac 275, 125-130
103. Bohn H (1991) J Cardiovasc Pharmacol 18, 522-527
104. Noack EA, Sandrock K, Hutter J (1992) Sulfhydryl-containing organic nitrates: a new class of nitrodilators with direct nitric oxide (NO)-donating properties. In: Biology of nitric oxide. (Moncada S, Marletta MA, Hibbs JB, eds) Portland Press, London, 28-29
105. Zanzinger J, Feelisch M, Bassenge E (1994) J Cardiovasc Pharmacol 23, 772-778
106. Lefer DJ, Siegfried MR, Ma XL (1993) J Cardiovasc Pharmacol 22 (Suppl 7), S27-S33
107. Cereda R, Agozzino S, Mascheroni G, Bergamaschi M, Gromo G, Mizrahi J (1993) Cardiovasc Drugs & Therap 7 (Suppl 2), 463, Abst 376
108. Civelli M, Giossi M, Caruso P, Razzetti R, Bergamaschi M, Bongrani S, Gasco A (1996) Br J Pharmac 118, 923-928
109. Karup G et al (1994) Pol J Pharmac 46, 541
110. Clozel M, Breu V, Gray G, et al (1994) J Pharmacol Exp Therap 270, 228-235
111. Seo FE, Oemar BS, Siebenmann R, Von Segesser L, Luscher TF (1993) Circulation 89, 1203-1208
112. Ohanaka K, Takayanagi R, Nishikawa M, Haji M, Nawata J (1993) J Biol Chem 268, 26759-26766
113. Clozel M, Breu V, Gray G, Loffer B (1993) J Cardiovasc Pharmacol 22 (Suppl 8), S377-S379
114. Willems H (1997) DDT 2, 85-87
115. Clozel M, Breu V (1996) FEBS Lett 383, 42-45
116. Spedding M (1985) Trends Pharmacol Sci 6, 109-114
117. Henry PD (1990) J Cardiovasc Pharmacol 16 (Suppl 1) S12-S15
118. Catapano AL (1997) Eur Heart J 18 (Suppl A), A80-A86
119. Van Zwieten PA (1986) Eur Neurol (Suppl), 57-67
120. Massingham R, John GW (1990) Overview of existing and future anti-ischaemic drugs. In: Drug treatment of cardiac ischaemia (van Zwieten P, Lie KI eds) Gustav Fischer, Stuttgart, 109-138
121. Kawakami M, Matsumura S, Shimamura T, Iwasaki T, Matsunaga K, Yonatan Y, Iwaki (1995) Jap J Pharmac 67 (Suppl 1), 269P
122. Nordlander M, Björkman JA, Regardh CG, Thalen P (1996) Br J Anaesth 76 (Suppl 1), 12 A24
123. Kaneko N (1994) Drug Dev Res 33, 429-438
124. Chatelain P, Gubin J (1993) Drugs 18, 817-832
125. Poty C, Gibon V, Evrard G, Norberg B, Vercauteren DP, Gubin J, Chatelain P, Durant F (1994) Eur J Med Chem 29, 911-923
126. Grosset A, Sabatier J, Villeneuve A, Gautier E, Pouyet T, Lainée P, O'Conner SE (1995) J Mol Cell Biol 27, A193
127. Kushida H, Nomura S, Hashimoto M (1996) Jap J Pharmac 71 (Suppl 1), 311P
128. Churl Chang K, Ok Pak C, Geun Hong S (1994) Drug Dev Res 33, 454-459
129. Furberg C, Psaty B, Meyer J (1995) Circulation 92, 1326-1331
130. Bush TL, Barret-Connor E, Cowan LD (1987) Circulation 75, 1002-1009
131. Ayres S, Tang M, Subbiah MTR (1996) J Lab Clin Med 128, 367-375
132. Nathan L, Pervin S, Singh R, Ricks J, Rosenfeld M, Chaudhuri G (1996) Circulation 8 (Suppl II), II51
133. Lefer AM, Tsao PS, Ma XL, Sampath TK (1992) J Mol Cell Cardiol 24, 585-593
134. Squadrito F, Altavilla D, Ammendolia L, Squadrito G, Campo GM, Sperandeo A, Canale P, Ioculano M, Saitta A, Caputi AP (1995) Br J Pharmac 115, 395-400
135. Oinuma H, Takamura T, Hasegawa T, Nomoto KI, Naitoh T, Daiku Y, Hamano S, Kakisawa H, Minami N (1991) J Med Chem 34, 2260-2267
136. Kishimoto TK, Rothlein R (1994) Adv Pharmacol 25, 117-169
137. Boschelli DH (1995) Drug 20, 805-816
138. Frenette PS, Wagner DD (1996) New Eng J Med 334, 1526-1529
139. Rubin H, Plotnick M, Wang Z, Liu X, Zhong Q, Schechter NM, Cooperman BS (1994) Biochemistry 33, 7627-7633
140. Murohara T, Guo JP, Lefer AM (1995) J Pharmac Exp Therap 274, 1246-1253
141. Lepran I, Ziegler D, Papp JG (1996) J Mol Cell Cardiol 28, A19
142. Hahn RA, MacDonald BR, Simpson PJ, Wang L, Towner RD, Ho PPK, Goodwin M, Breau AP, Suarez T, Mihelich ED (1991) J Pharmacol Exp Therap 256, 94-102
143. Mullane KM, Moncada S (1982) Prostaglandins 24, 255-266
144. Fiedler VB (1984) J Cardiovasc Pharmacol 6, 318-324
145. Nishida M, Kuzuya T, Hoshida S, Kim Y, Kamada T, Tada M (1987) Circulation 76 (Suppl IV), Abst 1921
146. Mullane K, Hatala MA, Kraemer R, Sessa W, Westlin W (1987) J Cardiovasc Pharmacol 10, 398-406
147. Bednar M, Smith B, Pinto A, Mullane KM (1985) Circ Res 57, 131-141
148. Janero DR, Burghardt B, Lopez R, Cardell M (1989) Biochem Pharmacol 38, 4381-4387
149. Nicholson CD, Challiss RA, Shahid M (1991) Trends Pharmacol Sci 12, 19-27
150. Minami M, Driscoll EM, Simpson PJ, Hoff PT, Lucchesi BR (1996) Pharmacology 50, 24-33
151. Stühmeier KD, Mainzer B, Cierpka J, Sandmann W, Tarnow J (1996) Anesthesiology 85, 706-712
152. Talke P, Li J, Jain U, Leung J, Drasner K, Hollenberg M, Mangano DT (1995) Anesthesiology 82, 620-633
153. Martin E, Motsch J, Ott E, van Aken H, van Hemelrijck J, Sonntag H, Kettler D, Mielck F, et al (1997) Anesthesiology 86, 346-363
154. Richer C, Gobert J, Noyer M, Wülfert E, Giudicelli JF (1996) Fundam Clin Pharmacol 10, 529-537
155. Wright RA, Decroly Ph, Kharkevitch T, Oliver MF, Gobert J, Wülfert E (1994) J Cardiothorac Vasc Anesth 8 (Suppl 2), 85
156. Riemersma RA, Debeer LJ (1997) Arzneim Forsch 47, 10-13
157. Kharkevitch T, Guyaux M, Gobert J, Wülfert E (1991) Cardiovasc Drugs & Therap 5 (Suppl 3), 407, P390
158. Guyaux M, Gobert J, Vandevelde M, Noyer M, Wülfert E (1997) Mivazerol prevents the tachycardia caused by emergence from halothane anesthesia partyl through activation of spinal α2-adrenoceptors. In: Acta Anaesthesiologica Scandinavica (accepted for publication)
159. Van Zwieten PA (1990) Eur J Clin Pharmacol 38, S 77-S 81
160. Nichols AJ, Sulpizio AC, Ashton DJ, Hieble JP, Ruffolo RR (1989) Pharmacology 39, 327-336
161. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH (1996) New Eng J Med 334, 1349-1355
162. Bril A, Slivjak M, DiMartino MJ, et al (1992) Cardiovasc Res 26, 518-525
163. Yue TL, Cheng HY, Lysko PG, McKenna PJ, Feuerstein R, Gu JL, Lysko KA, Davis LL, Feuerstein G (1992) J Pharmacol Exp Therap 263, 92-98
164. Feuerstein GZ, Yue TL, Cheng HY, Ruffolo RR (1993) J Hypertension 11 (Suppl 4) S41-S48
165. Brunvand H, Kvitting PM, Rynning SE, Berge RK, Grong K (1996) J Cardiovasc Pharmacol 28, 409-417
166. Mousa SA, Patil G, Mayo MC, Tong TM (1992) Int J Clin Pharmacol Therap Toxicol 30, 103-106
167. Iguchi S, Iwamura H, Nishizaki M, Hayashi A, Senokuchi K, Kobayashi K, Sakaki K, Hachiya K, Ichioka Y, Kawamura M (1992) Chem Pharm Bull 40, 1462-1469
168. Lin YT, Wu BN, Wu JR, Lo YC, Chen LC, Chen IJ (1996) J Cardiovasc Pharmacol 28, 149-157
169. Karmazyn M, Moffat MP (1993) Cardiovasc Res 27, 915-924
170. Noël J, Pouysségur J (1995) Am J Physiol 268, C283-C298
171. Scholz W, Abus U, Lang HJ, Linz W, Martorana PA, Englert HC, Schölkens BA (1993) Br J Pharmacol 109, 562-568
172. Scholz W, Abus U, Counillon L, Gögelein H, Lang HJ, Linz W, Weichter A, Schölkens BA (1995) Cardiovasc Res 29, 260-268
173. Kuno A (1996) Ann Drug Data Report 710-711
174. Packer M (1995) Eur Heart J 16 (Suppl F), 4-6
175. Cohn JN, Johnson G, Ziesche S, et al (1991) New Eng J Med 325, 303-310
176. Cohn JN, Simon A, Johnson G, and V-HeFT Study Group (1991) Circulation 84 (Suppl II) II-310
177. Husain A (1993) J Hypertension 11, 1155-1159
178. Yamazaki T, Komuro I, Nagai R, Yazaki Y (1996) Cardiovasc Res 31, 493-498
179. Juliano RL, Haskill, S (1993) J Cell Biol 120, 577-585
180. Wang N, Butler JP, Ingber DE (1993) Science 260, 1124-1127
181. Cawston TE (1996) Pharmacol Therap 70, 163-182
182. Hagmann WK, Lark MW, Becker JW (1996) Ann Reports Med Chem 31, 231-240